Eicosanoids, β-cell function, and diabetes

Prostaglandins and Other Lipid Mediators

Volumn 95, Issue 1-4, 2011, Pages 1-10

  Luo, Pengcheng ^a,b   Wang, Mong Heng ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b VANDERBILT UNIVERSITY   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cell destruction; Cell function; 12 HETE; Cyclooxygenase; Cytochrome P450; EETs; Lipoxygenase; PGE2; sEH

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; 12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 16 HYDROXYICOSATETRAENOIC ACID; 17 HYDROXYICOSATETRAENOIC ACID; 18 HYDROXYICOSATETRAENOIC ACID; 19 HYDROXYICOSATETRAENOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; 8,9 EPOXYICOSATRIENOIC ACID; ACETYLSALICYLIC ACID; CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; ICOSANOID; INDOMETACIN; LEUKOTRIENE A4; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LIPOXYGENASE; NORDIHYDROGUAIARETIC ACID; OMEGA 3 FATTY ACID; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DESTRUCTION; CELL FUNCTION; DRUG TARGETING; FATTY ACID METABOLISM; GENE DELETION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; REVIEW;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS; EICOSANOIDS; FATTY ACIDS, OMEGA-3; HUMANS; INSULIN-SECRETING CELLS; LIPOXYGENASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 79960837542     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.06.001     Document Type: Review

References (170)

1. J.E. Shaw, R.A. Sicree, and P.Z. Zimmet Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Res Clin Pract 87 2010 4 14
2. J.W. Yoon, and H.S. Jun Autoimmune destruction of pancreatic beta cells Am J Ther 12 2005 580 591
3. M. Cnop, N. Welsh, and J.C. Jonas Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities Diabetes 54 2005 S97 S107
4. D.L. Eizirik, M.L. Colli, and F. Ortis The role of inflammation in insulitis and beta-cell loss in type 1 diabetes Nat Rev Endocrinol 5 2009 219 226
5. G. Boden, and Obesity insulin resistance and free fatty acids Curr Opin Endocrinol Diabetes Obes 18 2011 139 143
6. K. Eckardt, A. Taube, and J. Eckel Obesity-associated insulin resistance in skeletal muscle: Role of lipid accumulation and physical inactivity Rev Endocr Metab Disord 2011 [Epub ahead of print]
7. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ Res 107 2010 1058 1070
8. C. Garcia, B. Feve, and P. Ferre Diabetes and inflammation: fundamental aspects and clinical implications Diabetes Metab 36 2010 327 338
9. J.C. Henquin Regulation of insulin secretion: a matter of phase control and amplitude modulation Diabetologia 52 2009 739 751
10. J.C. Henquin Pathways in beta-cell stimulus-secretion coupling as targets for therapeutic insulin secretagogues Diabetes 53 2004 S48 S58
11. J.D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol 279 2000 F965 F981
12. R.J. Roman P450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 2002 131 185 (Pubitemid 34654217)
13. J.D. Imig, and B.D. Hammock Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Nat Rev Drug Discov 8 2009 794 805
14. C.M. Hao, and M.D. Breyer Roles of lipid mediators in kidney injury Semin Nephrol 27 2007 338 351 (Pubitemid 46802920)
15. A.D. Dobrian, D.C. Lieb, and B.K. Cole Functional and pathological roles of the 12- and 15-lipoxygenases Prog Lipid Res 50 2011 115 131
16. J.D. Imig Eicosanoids and renal vascular function in diseases Clin Sci 111 2006 21 34 (Pubitemid 44023408)
17. R.C. Harris An update on cyclooxygenase-2 expression and metabolites in the kidney Curr Opin Nephrol Hypertens 17 2008 64 69 (Pubitemid 350295199)
18. M. Feletou, Y. Huang, and P.M. Vanhoutte Vasoconstrictor prostanoids Pflugers Arch 459 2010 941 950
19. M.S. Wong, and P.M. Vanhoutte COX-mediated endothelium-dependent contractions: from the past to recent discoveries Acta Pharmacol Sin 31 2010 1095 1102
20. J.R. Vane, Y.S. Bakhle, and R.M. Botting Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38 1998 97 120 (Pubitemid 28231490)
21. R.C. Harris COX-2 and the kidney J Cardiovasc Pharmacol 47 2006 S37 S42
22. H.F. Cheng, and R.C. Harris Cyclooxygenases, the kidney, and hypertension Hypertension 43 2004 525 530 (Pubitemid 38282421)
23. R.P. Robertson Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis Diabetes 47 1998 1379 1383
24. P.M. Vanhoutte COX-1 and vascular disease Clin Pharmacol Ther 86 2009 212 215
25. P.M. Vanhoutte, H. Shimokawa, and E.H. Tang Endothelial dysfunction and vascular disease Acta Physiol 196 2009 193 222
26. J. Kawabe, F. Ushikubi, and N. Hasebe Prostacyclin in vascular diseases - recent insights and future perspectives Circ J 74 2010 836 843
27. N.O. Camara, J.O. Martins, and R.G. Landgraf Emerging roles for eicosanoids in renal diseases Curr Opin Nephrol Hypertens 18 2009 21 27
28. N. Mochizuki, and Y.G. Kwon 15-lipoxygenase-1 in the vasculature: expanding roles in angiogenesis Circ Res 102 2008 143 145 (Pubitemid 351651114)
29. D. Poeckel, and C.D. Funk The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease Cardiovasc Res 86 2010 243 253
30. H. Kuhn, P. Chaitidis, and J. Roffeis Arachidonic Acid metabolites in the cardiovascular system: the role of lipoxygenase isoforms in atherogenesis with particular emphasis on vascular remodeling J Cardiovasc Pharmacol 50 2007 609 620 (Pubitemid 350307029)
31. C.M. Hao, and M.D. Breyer Physiologic and pathophysiologic roles of lipid mediators in the kidney Kidney Int 71 2007 1105 1115 (Pubitemid 46809137)
32. M.H. Wang Renal cytochrome P450-derived eicosanoids and hypertension Curr Hypertens Rev 2 2006 227 236
33. J.D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol 289 2005 F496 F503
34. J.D. Imig, L.G. Navar, and R.J. Roman Actions of epoxygenase metabolites on the preglomerular vasculature J Am Soc Nephrol 7 1996 2364 2370 (Pubitemid 27465940)
35. W.B. Campbell, D. Gebremedhin, and P.F. Pratt Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors Circ Res 78 1996 415 423 (Pubitemid 26072547)
36. Y. Chen, J.R. Falck, and V.R. Tuniki 20-125-Iodo-14,15-epoxyeicosa-5(Z)- enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site J Pharmacol Exp Ther 331 2008 1137 1145
37. I.A. Bukhari, K.M. Gauthier, and S.G. Jagadeesh 14,15-Dihydroxy-eicosa- 5(Z)-enoic acid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries J Pharmacol Exp Ther 336 2011 47 55
38. W. Yang, V.R. Tuniki, and S. Anjaiah Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125i-14,15-epoxyeicosa-8(Z)-enoic acid J Pharmacol Exp Ther 324 2008 1019 1027 (Pubitemid 351397827)
39. +-ATPase through a cytochrome P450 pathway Am J Physiol 266 1994 F497 F505
40. +-ATPase J Clin Invest 99 1997 1224 1230 (Pubitemid 27142758)
41. B. Escalante, J.R. Falck, and P. Yadagiri 19(S)-hydroxyeicosatetraenoic acid is a potent stimulator of renal Na, K-ATPase Biochem Biophys Res Commun 152 1988 1259 1274
42. B. Escalante, D. Erlij, and J.R. Falck Cytochrome P450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb Am J Physiol 266 1994 C1775 C1782
43. Y. Wei, D.H. Lin, and R. Kemp Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways J Gen Physiol 124 2004 719 727 (Pubitemid 39628138)
44. J.M. Williams, S. Murphy, and M. Burke 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension J Cardiovasc Pharmacol 56 2010 336 344
45. M.L. McDaniel, G. Kwon, and J.R. Hill Cytokines and nitric oxide in islet inflammation and diabetes Proc Soc Exp Biol Med 211 1996 24 32
46. J.C. Henquin Triggering and amplifying pathways of regulation of insulin secretion by glucose Diabetes 49 2000 1751 1760
47. C.Y. Zhang, G. Baffy, and P. Perret Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes Cell 105 2001 745 755 (Pubitemid 32635104)
48. S. Krauss, C.Y. Zhang, and L. Scorrano Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction J Clin Invest 112 2003 1831 1842 (Pubitemid 38063706)
49. S. Metz, M. VanRollins, and R. Strife Lipoxygenase pathway in islet endocrine cells: Oxidative metabolism of arachidonic acid promotes insulin release J Clin Invest 71 1983 1191 1205 (Pubitemid 13098905)
50. R.P. Robertson Arachidonic acid metabolite regulation of insulin secretion Diabetes Metab Rev 2 1986 261 296 (Pubitemid 16009510)
51. 3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function Diabetes 51 2002 1772 1778 (Pubitemid 34564289)
52. S.J. Persaud, D. Muller, and V.D. Belin The role of arachidonic acid and its metabolites in insulin secretion from human islets of Langerhans Diabetes 56 2007 197 203
53. S.J. Persaud, D. Muller, and V.D. Belin Expression and function of cyclooxygenase and lipoxygenase enzymes in human islets of Langerhans Arch Physiol Biochem 113 2007 104 109 (Pubitemid 47547382)
54. P.O. Tran, C.E. Gleason, and V. Poitout Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1beta J Biol Chem 274 1999 31245 31248
55. C.H. Sorli, H.J. Zhang, and M.B. Armstrong Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet Proc Natl Acad Sci 95 1998 1788 1793 (Pubitemid 28103472)
56. H. Fujita, M. Kakei, and H. Fujishima Effect of selective cyclooxygenase-2 (COX-2) inhibitor treatment on glucose-stimulated insulin secretion in C57BL/6 mice Biochem Biophys Res Commun 363 2007 37 43 (Pubitemid 47432915)
57. M.H. Nathan, and S.B. Pek Lipoxygenase-generated eicosanoids inhibit glucose-induced insulin release from rat islets Prostaglandins Leukot Essent Fatty Acids 40 1990 21 25 (Pubitemid 20145306)
58. S.A. Metz, R.C. Murphy, and W. Fujimoto Effects on glucose-induced insulin secretion of lipoxygenase-derived metabolites of arachidonic acid Diabetes 33 1984 119 124 (Pubitemid 14184696)
59. M. Mehrabian, F.T. Schulthess, and M. Nebohacova Identification of ALOX5 as a gene regulating adiposity and pancreatic function Diabetologia 51 2008 978 988
60. D. Bleich, S. Chen, and J.L. Gu The role of 12-lipoxygenase in pancreatic beta-cells Int J Mol Med 1 1998 265 272
61. B. Ahren, L.J. Magrum, and P.J. Havel Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat Obes Res 8 2000 475 480
62. D. Bleich, S. Chen, and B. Zipser Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice J Clin Invest 103 1999 1431 1436 (Pubitemid 29535499)
63. K. Ma, C.S. Nunemaker, and R. Wu 12-Lipoxygenase products reduce insulin secretion and {beta}-cell viability in human islets J Clin Endocrinol Metab 95 2010 887 893
64. J.R. Falck, S. Manna, and J. Moltz Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets Biochem Biophys Res Commun 114 1983 743 749 (Pubitemid 13030721)
65. D.C. Zeldin, J. Foley, and J.E. Boyle Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas Endocrinology 138 1997 1338 1346 (Pubitemid 27089795)
66. C.R. Lee, J.D. Imig, and M.L. Edin Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice FASEB J 24 2010 3770 3781
67. S. Mustafa, V. Sharma, and J.H. McNeill Insulin resistance and endothelial dysfunction: Are epoxyeicosatrienoic acids the link? Exp Clin Cardiol 14 2009 e41 e50
68. P. Luo, H.H. Chang, and Y. Zhou Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis J Pharmacol Exp Ther 334 2010 430 438
69. N.R. Barshes, S. Wyllie, and J.A. Goss Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts J Leukoc Biol 77 2005 587 597 (Pubitemid 40628740)
70. S.J. Persaud, C.J. Burns, and V.D. Belin Glucose-induced regulation of COX-2 expression in human islets of Langerhans Diabetes 53 2004 S190 S192
71. N. Shanmugam, I.T. Todorov, and I. Nair Increased expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advanced glycation endproduct-specific receptor (AGER), and in islets from diabetic mice Diabetologia 4 2006 100 107 (Pubitemid 43151620)
72. W. Xie, J.R. Merrill, and W.S. Bradshaw Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog Arch Biochem Biophys 300 1993 247 252 (Pubitemid 23225743)
73. T. Arakawa, O. Laneuville, and C.A. Miller Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells. Structure and expression of the murine prostaglandin EP4 receptor gene J Biol Chem 271 1996 29569 29575 (Pubitemid 26389577)
74. A. Rabinovitch, H. Baquerizo, and W. Sumoski Cytotoxic effects of cytokines on islet beta-cells: evidence for involvement of eicosanoids Endocrinology 126 1990 67 71 (Pubitemid 20037126)
75. 2 in the islets J Biol Chem 281 2006 29330 29336 (Pubitemid 44507076)
76. J.H. Juang, and C.H. Kuo Effects of cyclooxygenase-2 inhibitor and adenosine triphosphate-sensitive potassium channel opener in syngeneic mouse islet transplantation Transplant Proc 42 2010 4221 4224
77. C. Gysemans, K. Stoffels, and A. Giulietti Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents Diabetologia 46 2003 1115 1123 (Pubitemid 37041242)
78. M. Chen, Z.D. Yang, and K.M. Smith Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity Diabetologia 48 2005 486 495 (Pubitemid 40487296)
79. D.R. Laybutt, A. Sharma, and D.C. Sgroi Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia J Biol Chem 277 2002 10912 10921 (Pubitemid 34952846)
80. S.H. Fu, Y.T. Chen, and C.H. Chiang Enhancing engraftment of neonatal porcine xenoislet with CTLA4Ig and nordihydroguaiaretic acid Transplant Proc 38 2006 3283 3285
81. S. Yang, L. Lin, and J.X. Chen Cytochrome P450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways Am J Physiol 293 2007 H142 H151
82. A.N. Simpkins, R.D. Rudic, and D.A. Schreihofer Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection Am J Pathol 174 2009 2086 2095
83. A.E. Enayetallah, R.A. French, and M. Barber Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues J Histochem Cytochem 54 2006 329 335 (Pubitemid 43291277)
84. S.E. Kahn, R.L. Hull, and K.M. Utzschneider Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 444 2006 840 846 (Pubitemid 46024990)
85. M.I. McCarthy Genomics, type 2 diabetes, and obesity N Engl J Med 363 2010 2339 2350
86. I.E. Schauer, J.K. Snell-Bergeon, and B.C. Bergman Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: the CACTI study Diabetes 60 2011 306 314
87. D.E. Moller, and J.S. Flier Insulin resistance - mechanisms, syndromes, and implications N Engl J Med 325 1991 938 948
88. J.I. Odegaard, R.R. Ricardo-Gonzalez, and M.H. Goforth Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance Nature 447 2007 1116 1120 (Pubitemid 47014427)
89. S.P. Khanapure, D.S. Garvey, and D.R. Janero Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers Curr Top Med Chem 7 2007 311 340 (Pubitemid 46358664)
90. K.I. Williams, and G.A.G.A. Higgs Eicosanoids and inflammation J Pathol 156 1988 101 110
91. 2 of interleukin-6-dependent insulin resistance in hepatocytes Hepatology 50 2009 781 790
92. 2 actions in rat hepatocytes are mediated via different signalling pathways Eur J Biochem 218 1993 1083 1089 (Pubitemid 24010078)
93. P.S. Hsieh, J.S. Jin, and C.F. Chiang COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver Obesity 17 2009 1150 1157
94. N. Shanmugam, G. Gaw, and I.R. Natarajan Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes Diabetes 53 2004 795 802 (Pubitemid 38270651)
95. F. Cosentino, M. Eto, and P.P. De High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species Circulation 107 2003 1017 1023 (Pubitemid 36258726)
96. M. Schambelan, S. Blake, and J. Sraer Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus J Clin Invest 75 1985 404 412 (Pubitemid 15143479)
97. N. Shanmugam, Y.S. Kim, and L. Lanting Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products J Biol Chem 278 2003 34834 34844 (Pubitemid 37102242)
98. F. Miao, I.G. Gonzalo, and L. Lanting In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions J Biol Chem 279 2004 18091 18097 (Pubitemid 38560579)
99. F. Cipollone, A. Iezzi, and M. Fazia The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control Circulation 108 2003 1070 1077 (Pubitemid 37071516)
100. P.S. Hsieh, K.C. Lu, and C.F. Chiang Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats Eur J Clin Invest 40 2010 164 171
101. R.S. Hundal, K.F. Petersen, and A.B. Mayerson Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes J Clin Invest 109 2002 1321 1326 (Pubitemid 34546896)
102. W.L. Hasler, H.C. Soudah, and G. Dulai Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins Gastroenterology 108 1995 727 736
103. 2 synthase in the control of delayed type hypersensitivity Proc Natl Acad Sci 103 2006 5179 5184
104. D.W. Gilroy, P.R. Colville-Nash, and D. Willis Inducible cyclooxygenase may have anti-inflammatory properties Nat Med 5 1999 698 701 (Pubitemid 29289435)
105. T. Coll, X. Palomer, and F. Blanco-Vaca Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells Endocrinology 151 2010 537 548
106. E. Yapaci, O. Uysal, and H. Demirbilek Hypoglycaemia and hypothermia due to nimesulide overdose Arch Dis Child 85 2001 510 (Pubitemid 33116490)
107. Y.L. Konheim, and J.K. Wolford Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians Hum Genet 113 2003 377 381 (Pubitemid 37254241)
108. M.E. Rudock, Y. Liu, and J.T. Ziegler Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study Atherosclerosis 203 2009 459 465
109. J.A. Hubacek, T. Pelikanova, and V. Lanska A polymorphism in the cyclooxygenase 2 gene in type 1 diabetic patients with nephropathy Physiol Res 60 2011 377 380
110. A.R. Brash, and 1. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate J Biol Chem 274 1999 23679 23682
111. R. Natarajan, and J.L. Nadler Lipid inflammatory mediators in diabetic vascular disease Arterioscler Thromb Vasc Biol 24 2004 1542 1548 (Pubitemid 39180875)
112. D.D. Sears, P.D. Miles, and J. Chapman 12/15-Lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice PLoS One 4 2009 e7250
113. C.S. Nunemaker, M. Chen, and H. Pei 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet Am J Physiol 295 2008 E1065 E1075
114. I.K. Law, A. Xu, and K.S. Lam Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity Diabetes 59 2010 872 882
115. R. Natarajan, J.L. Gu, and J. Rossi Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells Proc Natl Acad Sci 90 1993 4947 4951 (Pubitemid 23182952)
116. M.K. Patricia, R. Natarajan, and A.N. Dooley Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells Circ Res 88 2001 659 665 (Pubitemid 32378134)
117. M.L. Brown, J.A. Jakubowski, and L.L. Leventis Elevated glucose alters eicosanoid release from porcine aortic endothelial cells J Clin Invest 82 1988 2136 2141 (Pubitemid 19054963)
118. S.K. Chakrabarti, Y. Wen, and A.D. Dobrian Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats Am J Physiol 300 2011 E175 E187
119. R. Horrillo, A. Gonzalez-Periz, and M. Martinez-Clemente 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity J Immunol 184 2010 3978 3987
120. M.E. Hatley, S. Srinivasan, and K.B. Reilly Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice J Biol Chem 278 2003 25369 25375 (Pubitemid 36835286)
121. M.L. Schwartzman, P. Iserovich, and K. Gotlinger Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy Diabetes 59 2010 1780 1788
122. Y. Wen, J. Gu, and S.K. Chakrabarti The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages Endocrinology 148 2007 1313 1322
123. Y. Wen, J. Gu, and G.E. Vandenhoff Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages Am J Physiol 294 2008 H1933 H1938
124. S.K. Chakrabarti, B.K. Cole, and Y. Wen 12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes Obesity 17 2009 1657 1663
125. K.A. Scribner, T.M. Gadbois, and M. Gowri Masoprocol decreases serum triglyceride concentrations in rats with fructose-induced hypertriglyceridemia Metabolism 49 2000 1106 1110
126. M.J. Reed, K. Meszaros, and L.J. Entes Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of type 2 diabetes Diabetologia 42 1999 102 106 (Pubitemid 29039746)
127. E. Alpert, A. Gruzman, and H. Totary A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: Role of glucose and 12-hydroxyeicosatetraenoic acid Biochem J 362 2002 413 422 (Pubitemid 34214484)
128. A.D. Dobrian, D.C. Lieb, and O. Ma Differential expression and localization of 12/15 lipoxygenases in adipose tissue in human obese subjects Biochem Biophys Res Commun 403 2010 485 490
129. M. Kaaman, M. Ryden, and T. Axelsson ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance Int J Obes 30 2006 447 452
130. I. Antonipillai, J. Nadler, and E.J. Vu A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease J Clin Endocrinol Metab 81 1996 1940 1945 (Pubitemid 26152489)
131. Y. Yamada, K. Kato, and M. Oguri Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome Int J Mol Med 21 2008 801 808
132. T. Yoshida, K. Kato, and K. Yokoi Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus Int J Mol Med 23 2009 529 537
133. Y. Liu, B.I. Freedman, and K.P. Burdon Association of arachidonate 12-lipoxygenase genotype variation and glycemic control with albuminuria in type 2 diabetes Am J Kidney Dis 52 2008 242 250 (Pubitemid 351978132)
134. K.P. Burdon, M.E. Rudock, and A.B. Lehtinen Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study Mediat Inflamm 2010 [Epub ahead of print]
135. G.J. Pass, W. Becker, and R. Kluge Effect of hyperinsulinemia and type 2 diabetes-like hyperglycemia on expression of hepatic cytochrome P450 and glutathione s-transferase isoforms in a New Zealand obese-derived mouse backcross population J Pharmacol Exp Ther 302 2002 442 450 (Pubitemid 34787206)
136. X. Zhao, A. Dey, and O.P. Romanko Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats Am J Physiol 288 2005 R188 R196
137. J.L. Lam, Y. Jiang, and T. Zhang Expression and functional analysis of hepatic cytochromes P450, nuclear receptors, and membrane transporters in 10- and 25-week-old db/db mice Drug Metab Dispos 38 2010 2252 2258
138. A. Enriquez, I. Leclercq, and G.C. Farrell Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats Biochem Biophys Res Commun 255 1999 300 306 (Pubitemid 29292254)
139. D.L. Kroetz, P. Yook, and P. Costet Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes J Biol Chem 273 1998 31581 31589 (Pubitemid 28533182)
140. P. Luo, Y. Zhou, and H.H. Chang Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy Am J Physiol 296 2009 F556 F563
141. P.V. Katakam, M. Hoenig, and H.R. Ujhelyi Cytochrome P450 activity and endothelial dysfunction in insulin resistance J Vasc Res 37 2000 426 434
142. Y. Park, S. Capobianco, and X. Gao Role of EDHF in type 2 diabetes-induced endothelial dysfunction Am J Physiol 295 2008 H1982 H1988
143. X. Xu, C.X. Zhao, and L. Wang Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice Diabetes 59 2010 997 1005
144. L.N. Zhang, J. Vincelette, and D. Chen Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension Eur J Pharmacol 654 2011 68 74
145. J.M. Do Carmo, A.A. da Silva, and J. Morgan Inhibition of soluble epoxide hydrolase reduces food intake and increases metabolic rate in obese mice Nutr Metab Cardiovasc Dis 2010 [Epub ahead of print]
146. K. Sodhi, K. Inoue, and K.H. Gotlinger Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice J Pharmcol Exp Ther 331 2009 906 916
147. X. Zhao, and L.Y. Li PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats Am J Nephrol 28 2008 98 606
148. M.H. Yousif, and I.F. Benter Role of cytochrome P450 metabolites of arachidonic acid in regulation of corporal smooth muscle tone in diabetic and older rats Vascul Pharmacol 47 2007 281 287 (Pubitemid 350008129)
149. K. Ohtoshi, H. Kaneto, and K. Node Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients Biochem Biophys Res Commun 331 2005 347 350 (Pubitemid 40545182)
150. A. Surendiran, S.C. Pradhan, and A. Agrawal Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients Eur J Clin Pharmacol 2011 [Epub ahead of print]
151. K. Zhou, L. Donnelly, and L. Burch Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study Clin Pharmacol Ther 87 2010 52 56
152. G. Ragia, I. Petridis, and A. Tavridou Presence of CYP2C9*3 allele increases risk for hypoglycemia in type 2 diabetic patients treated with sulfonylureas Pharmacogenomics 10 2009 1781 1787
153. A. Weise, S. Prause, and M. Eidens Prevalence of CYP450 gene variations in patients with type 2 diabetes Clin Lab 56 2010 311 318
154. C.P. Wang, W.C. Hung, and T.H. Yu Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history Exp Clin Endocrinol Diabetes 118 2010 346 352
155. J.J. Swen, J.A. Wessels, and A. Krabben Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with type 2 diabetes mellitus Pharmacogenomics 11 2010 1517 1523
156. S. Semiz, T. Dujic, and B. Ostanek Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus Bosn J Basic Med Sci 10 2010 287 291
157. M. Lajer, L. Tarnow, and S. Andersen CYP2C9 variant modifies blood pressure-lowering response to losartan in type 1 diabetic patients with nephropathy Diabet Med 24 2007 323 325
158. L. Pucci, D. Lucchesi, and V. Chirulli Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetes mellitus Am J Pharmacogenomics 3 2003 355 358 (Pubitemid 37409108)
159. P.C. Calder n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases Am J Clin Nutr 83 2006 S1505 S1519
160. A. Konkel, and W.H. Schunck Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids Biochim Biophys Acta 1814 2011 210 222
161. D. Wei, J. Li, and M. Shen Cellular production of n-3 PUFAs and reduction of n-6 to n-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death Diabetes 59 2010 471 478
162. J. Bellenger, S. Bellenger, and A. Bataille High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: Inflammatory pathway inhibition Diabetes 60 2011 1090 1099
163. T. Linn, M. Noke, and M. Woehrle Fish oil-enriched diet and reduction of low-dose streptozocin-induced hyperglycemia. Inhibition of macrophage activation Diabetes 38 1989 1402 1411 (Pubitemid 19271722)
164. A. Gonzalez-Periz, R. Horrillo, and N. Ferre Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: A role for resolvins and protectins FASEB J 23 2009 1946 1957
165. T.A. Mori, D.Q. Bao, and V. Burke Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects Am J Clin Nutr 70 1999 817 825 (Pubitemid 29512906)
166. J.C. Lovejoy The influence of dietary fat on insulin resistance Curr Diab Rep 2 2002 435 440
167. J.D. Bagdade, M. Ritter, and P.V. Subbaiah Marine lipids normalize cholesteryl ester transfer in IDDM Diabetologia 39 1996 487 491 (Pubitemid 26096301)
168. T. Tabatabaie, A.M. Waldon, and J.M. Jacob COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice Biochem Biophys Res Commun 273 2000 699 704 (Pubitemid 30599047)
169. G. Rai, V. Kenyon, and A. Jadhav Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1 J Med Chem 53 2010 7392 7404
170. C. Arnold, M. Markovic, and K. Blossey Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids J Biol Chem 285 2010 32720 32733